Home » Authors » Mark Lawson

Mark Lawson

Articles

ARTICLES

Court Documents Reveal GSK's Stand On Relenza

June 15, 2005

Court Documents Reveal GSK's Stand On Relenza

June 15, 2005

Investor Interest Wanes For Australia's Biotech Stocks

April 20, 2005

Investor Interest Wanes For Australia's Biotech Stocks

April 20, 2005

Australian Stock Exchange: Commissioned Reports OK

Feb. 9, 2005

Australian Stock Exchange: Commissioned Reports OK

Feb. 9, 2005

Metabolic Jumps, Slides On Trial Data, Analyst Criticism

Dec. 22, 2004

Metabolic Jumps, Slides On Trial Data, Analyst Criticism

Dec. 22, 2004

Peptech, J&J Unit Centocor Settle Remicade IP Dispute

Nov. 24, 2004

Peptech, J&J Unit Centocor Settle Remicade IP Dispute

Nov. 24, 2004

View All Articles by Mark Lawson

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...